$LLY

LLYEli Lilly and Company Common Stock

What are people saying about Eli Lilly and Company (LLY) stock on YouTube?

In the past 30 days (As of 11-18), 9 YouTube channels discussed Eli Lilly and Company (LLY) in 15 entries. Most recent: Schwab Network, 2026-11-16.

All takes and content in this window

As of 11-18
11-06
“Stock Market Warning: Tech Sells Off as Money Moves HERE!”
$LLYBullish
AI summary · Eli Lilly is expensive but just reached the buy zone today and, on a fresh plus base, offers another chance to buy; Lilly looks quite promising now because the medical trade is quite active.

This is an expensive stock. Its name is Eli Lilly and it just arrived at the Buy Zone today and gave you another chance. I believe they always give you another chance. And it's on a nice fresh plus base.

It went up and because the market was bad, it gave you another chance. So stocks like Lilly look quite promising now because the medical trade is quite active now.

11-16
Schwab NetworkPublished 2026-11-16
“Adam Coons On Defense; "No Touch" on NVDA, Avoiding HD and LOW Pre-Earnings”
$LLYBullish
AI summary · Eli Lilly is somewhat defensive; continued obesity-drug launches, with Retatrutide/GLP-3 next, may make it a game-changer that eliminates the competition. The speaker says LLY, like Google, has 10 to 20% upside potential, and both can outperform for different reasons and in different scenarios.

Share like Google that you liked. I mean, it saw that decline after the earnings, but it was in a somewhat upward trend. And Eli Lily. Do you think both of these stocks have a 10 to 20% upside potential?

As for Eli Lilly, it is once again a somewhat defensive stock , but the products they are putting forward and we see a continuation of the introduction of various obesity drugs.

I believe "Retatrotide" is next in the production line. Some people call it "GLP-3". This drug is likely to be a game-changer for them in this field, and may eliminate the rest of the competition.

11-13
Schwab NetworkPublished 2026-11-13
“PPI Mostly Cool, AI at "Crossroads" Amid NVDA CEO Search”
$LLYBullish
11-12
Schwab NetworkPublished 2026-11-12
“The Big 3: JNJ, LLY, AAPL”
$LLYBullish
AI summary · Eli Lilly is technically strong and the speaker expects a measured upward move: faster moving averages favor bulls, though it has not convincingly broken the 14.50 ceiling and RSI shows a bearish divergence. He prefers an options structure to capture upside while limiting downside, targeting 1560–1600 and an ideal 8–10% rise; the stock is expensive and hard for options, while healthcare should stay relatively strong into 2027.

Your next choice is also in the healthcare sector. We have Eli Lilly. I mean, perhaps Eli Lilly's chart is more technically clear. So , what is your outlook for Lilly? A similar view.

The momentum is definitely there from a technical standpoint. But again, I fundamentally believe that the healthcare sector will continue to demonstrate relative strength as we enter 2027.

It is an expensive stock. It is difficult to structure options positions on it due to the size of the stock and the cost of the options as well. However, I still believe there are opportunities, and that's why when I looked at the trading example today, the focus was on structuring a deal around options.

Therefore, to some extent, we identify downside risks with the ability to capture upward price movements.

11-10
Parkev Tatevosian, CFAPublished 2026-11-10
“My Forever Portfolio: 4 Spectacular Stocks You Can Buy Now and Never Sell”
$LLYBullish
AI summary · Eli Lilly is a buy-and-hold-forever recommendation because its decades of serial successes, not just weight-loss treatments, make the current success non-fleeting; with the stock at $1,366 versus his $1,662 valuation, he owns shares and wants to add more.

What you see here is my valuation, and my discounted cash flow model for the first stock I'm going to mention that you can buy now and hold forever, which is Eli Lilly.

Eli Lilly is a pharmaceutical company with decades of experience in researching and developing treatments that generate billions of dollars in sales and profits. Currently, the company is benefiting from its recent success in weight loss treatments, but the company has a history of one success after another.

11-07
Everything MoneyPublished 2026-11-07
“Why The Nasdaq is Really Crashing in 2026 (Sell Now or Buy the Dip?)”
$LLYBearish
11-03
T3 LivePublished 2026-11-03
“Scott Redler’s #630club - LIVE Premarket Stock Market Update”
$LLYBullish
AI summary · LLY has been doing absolutely fantastic and is technically acting well — it gave a move higher and held the eight-day; the speaker says to see whether the 1387 low holds.

So many freaking broken stuff. Yes, non tech looks okay. So, if you want to be in Eli Liy, Eli Liy has been doing absolutely fantastic. You know, if you want to take a pill to lose weight, I'm not judging you.

You could do that, too. I'm going to go on my son and my ice barrel and I'm going to sweat. But 7% of the world is taking pills to lose weight. Okay. Anyway, um stock technically has been acting well.

Gave you a move, held the eight day. Um go, you know, I have a friend who who's paying for every one of his kids college because he named his little daughter Lily. And uh Lily has had a tremendous run.

It's down 11 1397. Um what's this low here? 1387. So, um, see if that holds.

What they said to watch for
11-02
Verified InvestingPublished 2026-11-02
“Oil Drops Sharply Triggering Market Surge, Silver Bounces As AI Tech Trade Is Back On, Top Trades!”
$LLYBearish
AI summary · Eli Lilly is one of the speaker's favorite shorts right now. After new record highs while the AI trade collapsed, Friday's small doji could be a reversal signal and a decline may be starting. He watches for a drop to around 1290 to fill the gap at the pivot, a classic pullback setup.

One of my favorite short-selling deals right now, guys, is this one. Eli Lilly. Eli Lilly again, if you go to your monthly chart, you would swear and I would swear that this is an AI stock, but it is actually a pharmaceutical stock.

A major movement recently in artificial intelligence. Look at this upward movement here: while the AI trade was collapsing, Eli Lilly rose to new record highs. A small "Doji" candlestick was recorded on Friday, which could be a reversal signal.

Once again, there is a possibility of a decline beginning. I'll be watching for a drop to around 1290 here. Bridging this gap also represents the peak of this pivot point here, isn't it?

So again, bridge the gap there and then that pivot point there. A classic pullback opportunity seems likely in Eli Lilly's stock setup .

Showing 8 / 15 on this page
See this ticker’s full history